CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Downgrades Biohaven to Sector Perform From Outperform, Cuts Price Target to $19 From $23, Keeps Speculative Risk

Negative
AI Analysis

Summary

RBC Capital Markets downgraded Biohaven from Outperform to Sector Perform and cut its price target from $23 to $19, maintaining a speculative risk designation on the stock.

Importance:4/10
Sentiment:
-0.60
analyst_downgradeprice_target_cutrating_change
Related Companies

Read the original article

Published by yahoo_finance on September 8, 2026 11:03 AM

Read Original